Supplemental Cash Flow Information - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Supplemental cash flow information:
Interest paid	$ 2,878	$ 3,853
Income taxes paid	4,223	1,738
Supplemental disclosure of non-cash investing and financing activities:
Right-of-use asset obtained in exchange for new operating lease liability	7,288	3,908
Reclassification of contingently redeemable common stock in connection with IPO	0	309,500
Issuance of Common Stock Under Partner Physician Group Equity Agreements Upon IPO	0	268,467
Offering Costs Accrued At End Of Period	0	295
Non-cash investment in unconsolidated subsidiaries	$ 190	$ 763